• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD Back to Search Results
Catalog Number 1012464-18
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Death (1802); Thrombosis (2100); Respiratory Failure (2484)
Event Date 04/03/2017
Event Type  Death  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The scaffold remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all relevant information.
 
Event Description
It was reported that on (b)(6) 2015, the patient was admitted with anterior st elevation myocardial infarction.A 3.5 x 18 mm absorb bioresorbable vascular scaffold (bvs) was implanted in the proximal left anterior descending (lad) artery to treat 100% stenosis and reducing stenosis to 0%.Moderate to severe disease was noted in the mid left circumflex/2nd obtuse marginal artery; however, this was treated with optimal medical therapy.In (b)(6) 2016, dual antiplatelet therapy (dapt) was stopped.The patient continued on aspirin.On (b)(6) 2017, the patient collapsed.Cardiopulmonary resuscitation (cpr) was initiated by a bystander and also by ambulance crew.The patient was transferred to the emergency room.Upon arrival, the patient was unresponsive to cpr and not tolerating airway.Intravenous fluids were started and cpr continued.A chest compression device was used and medication was administered.Agonal breathing was noted, as well as metabolic disturbance not compatible with survival.Resuscitation attempts were stopped and the patient died.It was suspected that the event may have been caused by stent thrombosis.No autopsy was performed.Cause of death was reported as cardiac arrest and ischemic heart disease.There was no additional information provided.
 
Manufacturer Narrative
(b)(4).There was no reported device malfunction and the product was not returned as the scaffold remains in the anatomy.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of cardiac arrest, death and thrombosis, as listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use are a known adverse event associated with the use of a coronary scaffold in native coronary arteries.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined and there is no indication of a product quality issue with respect to design, manufacture or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE DRUG ELUTING SCAFFOLD
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key6941203
MDR Text Key89008001
Report Number2024168-2017-08142
Device Sequence Number1
Product Code PNY
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,s
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 10/17/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/11/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/06/2015
Device Catalogue Number1012464-18
Device Lot Number4040761
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/12/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/01/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ASPIRIN
Patient Outcome(s) Death;
Patient Age72 YR
Patient Weight97
-
-